In an unprecedented downturn, the Nifty has faced its longest losing streak in 25 years, sliding for over eight weeks as foreign investors ...

Indian equity benchmarks recovered in Monday's session, breaking a four-day losing streak and reflecting positive global trends. The Sensex...

The government is actively exploring a proposal to expand central licensing authority over all sterile drug products following a recent Sup...

Indian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...

Indian equity markets rebounded on Monday, with the Nifty and Sensex rising 0.60% and 0.66%, respectively. ITC led the gainers, while HCL T...

India is set to implement significant reforms to the goods and services tax system, which will ease compliance. Changes may include the rel...

In this edition, we present a 10-year performance tracker of various domestic market sectors. The annual returns are ranked for 9 key NSE S...

Indian equities continued their downward trend due to rising global bond yields and high crude oil prices. The Nifty 50 fell by 198.50 poin...

The technical structure has weakened materially, with the most important development being the Nifty's modest violation of its 200-week mov...

The fund house noted that the geopolitical crisis in the Middle East had entered its eighth month and resulted in severe disruptions to glo...

India’s white-collar hiring grew 2% year-on-year in September, with the Naukri JobSpeak Index rising to 3,053 from 3,002 a year earlier. AI...

Hospital stocks extended losses for a second session after the Supreme Court questioned steep markups on cancer drugs and raised concerns o...

The Indian stock market saw further declines as the Sensex dipped nearly 49 points while the Nifty sank around 96 points by session's end. ...

Electronics manufacturing companies have received substantial incentives under the production-linked incentive scheme and attracted signifi...

Jagsonpal Pharmaceuticals has signed a business transfer agreement to acquire the wellness portfolio of Group Pharmaceuticals. The acquisit...

India's pharmaceutical sector is projected to grow at 11-13 percent this fiscal year due to export increases. The domestic market is also e...

HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...